(VRNM, ALGN, GGS) CRWENewswire Stocks to Watch
Verenium Corp - VRNM - reported an agreement with Tate & Lyle for the use of one of its proprietary enzyme products in the development of novel food ingredients. Under the terms of the agreement, Verenium receives $1.5 million in near term milestone payments, revenues from enzyme product sales, and a royalty on Tate & Lyle’s future sales. On its Fourth Quarter Fiscal 2011, Align Technology Inc -ALGN - posted record net revenues of $128.9 million, a 2.4% increase sequentially and 38.8% year-over-year. PanGeo Subsea Inc and Global Geophysical Services Inc - GGS - reported that they have entered into an agreement for the development and commercialization of the Acoustic Zoom product line.

*********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Diasclaimer at http://www.crwenewswire.com/disclaimer)

ユーザー：karmastock
再生時間：00:01:19
投稿日時：12/01/31 10:23
カテゴリ：ビジネス全般 
タグ： VRNM  ALGN  GGS  Nasdaq:VRNM  Nasdaq:ALGN  NYSE:GGS 

[ 前ページへ戻る ]